HomeNYMXF • OTCMKTS
add
Nymox Pharmaceutical Corp
Previous close
$0.10
Day range
$0.13 - $0.13
Year range
$0.00010 - $1.40
Market cap
11.87M USD
Avg Volume
38.08K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 653.00K | -35.60% |
Net income | -716.00K | 30.89% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -652.67K | 35.44% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 41.00K | -46.05% |
Total assets | 624.00K | -6.73% |
Total liabilities | 6.92M | 169.16% |
Total equity | -6.30M | — |
Shares outstanding | 93.54M | — |
Price to book | -1.43 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -716.00K | 30.89% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1989
Website
Employees
3
